Literature DB >> 18849143

Lupus-like autoantibody development in rabbits and mice after immunization with EBNA-1 fragments.

Brian D Poole1, Timothy Gross, Shannon Maier, John B Harley, Judith A James.   

Abstract

Epstein-Barr virus has been implicated in the etiology of systemic lupus erythematosus (SLE) through serologic and immunologic studies. A potential mechanism for this influence is through molecular mimicry. The EBV nuclear antigen EBNA-1 contains a region, PPPGRRP, with considerable homology to the initial sequence targeted by antibodies in Sm B' autoimmunity, PPPGMRPP. This study examined whether immunization of rabbits and mice with peptides containing the PPPGRRP sequence from EBNA-1 constructed on a poly-lysine backbone was able to drive the development of autoantibodies against the Smith antigen (Sm) and the related antigenic complex, the U1 nuclear ribonucleoproteins (nRNPs). PPPGRRP immunization, and immunization with an EBNA-1 fragment containing PPPGRRP, led to autoantibodies in both rabbits and mice at high frequency (83% of rabbits and 43% of mice). Five out of six immunized rabbits developed either leucopenia or lymphopenia or both. The fine specificity of antibody binding against the lupus-associated autoantigens Sm B', nRNP A, and nRNP C after immunization with the EBNA-1-derived peptides was very similar to the early antibody binding patterns against these proteins in human SLE. This similarity, as well as the prevalence of autoimmunity after immunization with these peptides, identifies PPPGRRP as a strong candidate for molecular mimicry in SLE etiology.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18849143      PMCID: PMC2852321          DOI: 10.1016/j.jaut.2008.08.007

Source DB:  PubMed          Journal:  J Autoimmun        ISSN: 0896-8411            Impact factor:   7.094


  35 in total

1.  Systemic lupus erythematosus in adults is associated with previous Epstein-Barr virus exposure.

Authors:  J A James; B R Neas; K L Moser; T Hall; G R Bruner; A L Sestak; J B Harley
Journal:  Arthritis Rheum       Date:  2001-05

Review 2.  Key sequences involved in the spreading of the systemic autoimmune response to spliceosomal proteins.

Authors:  F Monneaux; S Muller
Journal:  Scand J Immunol       Date:  2001 Jul-Aug       Impact factor: 3.487

3.  Lupus humoral autoimmunity after short peptide immunization.

Authors:  J A James; R H Scofield; J B Harley
Journal:  Ann N Y Acad Sci       Date:  1997-04-05       Impact factor: 5.691

4.  The epitopes for natural polyreactive antibodies are rich in proline.

Authors:  B Tchernychev; S Cabilly; M Wilchek
Journal:  Proc Natl Acad Sci U S A       Date:  1997-06-10       Impact factor: 11.205

5.  Immune responses to small nuclear ribonucleoproteins: antigen-dependent distinct B cell epitope spreading patterns in mice immunized with recombinant polypeptides of small nuclear ribonucleoproteins.

Authors:  Umesh S Deshmukh; Carol C Kannapell; Shu Man Fu
Journal:  J Immunol       Date:  2002-05-15       Impact factor: 5.422

6.  Shared early autoantibody recognition events in the development of anti-Sm B/B' in human lupus.

Authors:  M R Arbuckle; M Reichlin; J B Harley; J A James
Journal:  Scand J Immunol       Date:  1999-11       Impact factor: 3.487

7.  High prevalence of immunoglobulin A antibody against Epstein-Barr virus capsid antigen in adult patients with lupus with disease flare: case control studies.

Authors:  Chung-Jen Chen; Kuei-Hsiang Lin; Shih-Chang Lin; Wen-Chan Tsai; Jeng-Hsien Yen; Shun-Jen Chang; Sheng-Nan Lu; Hong-Wen Liu
Journal:  J Rheumatol       Date:  2005-01       Impact factor: 4.666

8.  An increased prevalence of Epstein-Barr virus infection in young patients suggests a possible etiology for systemic lupus erythematosus.

Authors:  J A James; K M Kaufman; A D Farris; E Taylor-Albert; T J Lehman; J B Harley
Journal:  J Clin Invest       Date:  1997-12-15       Impact factor: 14.808

9.  A limited lupus anti-spliceosomal response targets a cross-reactive, proline-rich motif.

Authors:  M R Arbuckle; A R Schilling; J B Harley; J A James
Journal:  J Autoimmun       Date:  1998-10       Impact factor: 7.094

10.  Interaction between the U1 snRNP-A protein and the 160-kD subunit of cleavage-polyadenylation specificity factor increases polyadenylation efficiency in vitro.

Authors:  C S Lutz; K G Murthy; N Schek; J P O'Connor; J L Manley; J C Alwine
Journal:  Genes Dev       Date:  1996-02-01       Impact factor: 11.361

View more
  41 in total

Review 1.  Immune modulation during latent herpesvirus infection.

Authors:  Douglas W White; R Suzanne Beard; Erik S Barton
Journal:  Immunol Rev       Date:  2012-01       Impact factor: 12.988

2.  HLA-DRB1 the notorious gene in the mosaic of autoimmunity.

Authors:  María-Teresa Arango; Carlo Perricone; Shaye Kivity; Enrica Cipriano; Fulvia Ceccarelli; Guido Valesini; Yehuda Shoenfeld
Journal:  Immunol Res       Date:  2017-02       Impact factor: 2.829

Review 3.  Molecular mimicry, genetic homology, and gene sharing proteomic "molecular fingerprints" using an EBV (Epstein-Barr virus)-derived microarray as a potential diagnostic method in autoimmune disease.

Authors:  David H Dreyfus; Antonella Farina; Giuseppina Alessandra Farina
Journal:  Immunol Res       Date:  2018-12       Impact factor: 2.829

Review 4.  Inflammasome activation by nucleic acids and nucleosomes in sterile inflammation… or is it sterile?

Authors:  Christopher R Lupfer; Angeline Rodriguez; Thirumala-Devi Kanneganti
Journal:  FEBS J       Date:  2017-04-26       Impact factor: 5.542

5.  Promoter variant of PIK3C3 is associated with autoimmunity against Ro and Sm epitopes in African-American lupus patients.

Authors:  Silvia N Kariuki; Beverly S Franek; Rachel A Mikolaitis; Tammy O Utset; Meenakshi Jolly; Andrew D Skol; Timothy B Niewold
Journal:  J Biomed Biotechnol       Date:  2010-07-04

6.  60 kD Ro and nRNP A frequently initiate human lupus autoimmunity.

Authors:  Latisha D Heinlen; Micah T McClain; Lauren L Ritterhouse; Benjamin F Bruner; Colin C Edgerton; Michael P Keith; Judith A James; John B Harley
Journal:  PLoS One       Date:  2010-03-10       Impact factor: 3.240

7.  Serum concentration of immunoglobulin G-type antibodies against the whole Epstein-Barr nuclear antigen 1 and its aa35-58 or aa398-404 fragments in the sera of patients with systemic lupus erythematosus and multiple sclerosis.

Authors:  D Csuka; D Simon; R Hóbor; K Uray; Z Prohászka; Z Bánlaki; P K Jani; Á Szilágyi; F Hudecz; K Rajczy; G Beke; A Boros Major; A Tordai; Z Illés; T Berki; L Czirják; G Füst
Journal:  Clin Exp Immunol       Date:  2013-03       Impact factor: 4.330

Review 8.  The role of the Epstein-Barr virus in the pathogenesis of some autoimmune disorders - Similarities and differences.

Authors:  G Füst
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2011-12-23

9.  Editorial: What caused all these troubles, anyway? Epstein-Barr virus in Sjögren's syndrome reevaluated.

Authors:  John B Harley; Erin E Zoller
Journal:  Arthritis Rheumatol       Date:  2014-09       Impact factor: 10.995

10.  Reduced IgG anti-small nuclear ribonucleoprotein autoantibody production in systemic lupus erythematosus patients with positive IgM anti-cytomegalovirus antibodies.

Authors:  Claudia Azucena Palafox Sánchez; Minoru Satoh; Edward Kl Chan; Wendy C Carcamo; José Francisco Muñoz Valle; Gerardo Orozco Barocio; Edith Oregon Romero; Rosa Elena Navarro Hernández; Mario Salazar Páramo; Antonio Cabral Castañeda; Mónica Vázquez Del Mercado
Journal:  Arthritis Res Ther       Date:  2009-02-20       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.